DIH Holding US, Inc. DHAI

DHAI Company Overview

DIH Holding US, Inc. is a publicly traded medical technology company that develops, manufactures, and commercializes diagnostic and rehabilitation solutions primarily for cardiovascular, pulmonary, and physical therapy applications. The company operates within the medical devices and healthcare technology industries, focusing on clinical assessment, rehabilitation, and performance monitoring across the continuum of care. Its solutions are used by hospitals, outpatient clinics, rehabilitation centers, and sports performance facilities.

The company’s primary revenue drivers are hardware systems, recurring software licenses, and service contracts associated with diagnostic testing and rehabilitation platforms. DIH Holding is positioned as an integrated provider combining data-driven diagnostics with therapy solutions, differentiating itself through clinically validated technologies and a portfolio that spans evaluation through recovery. The company was formed through the merger of several established healthcare technology businesses and completed a public listing via a special purpose acquisition company transaction in 2022, consolidating complementary brands under a single operating structure.